Literature DB >> 24965607

Programme to provide Quebec infants with free vitamin D supplements failed to encourage participation or adherence.

Maude Millette1, Atul Sharma, Hope Weiler, Odile Sheehy, Anick Bérard, Celia Rodd.   

Abstract

AIM: The aim of this study was to evaluate the uptake of a free vitamin D infant prescription programme and to determine the incidence of nutritional rickets.
METHODS: This was a retrospective cohort study of infants from Quebec, Canada, involving term infants born between 1998 and 2008 and covered by the public insurance programme. Data were extracted from the Quebec Pregnancy Cohort. Predictors of programme participation were identified through logistic regression.
RESULTS: A total of 123 018 infants were eligible, and the mean annual prevalence of supplemental vitamin D exposure was 17.9 ± 5.6%. The median age for obtaining the first bottle was 36 days and half only obtained one bottle of 50 doses. Mothers with higher socio-economic status, those who lived as a couple, older mothers or a prescription by a paediatrician significantly increased the odds of obtaining vitamin D. There was a decline in programme participation over time (OR 0.89/year, 95% CI = 0.88-0.90). The incidence of rickets was 23.9 cases per 100 000 live births, with an annual increase of 1.12 cases/year (95% CI = 1.01-1.24).
CONCLUSION: Without educational measures, a free prescription programme for vitamin D failed to encourage participation or adherence. Moreover, participation decreased with time. New strategies, including educational support, need to be developed to increase vitamin D supplementation rates. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  infant; rickets; supplements; vitamin D

Mesh:

Substances:

Year:  2014        PMID: 24965607     DOI: 10.1111/apa.12727

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Adherence to the infant vitamin D supplementation policy in Ireland.

Authors:  A Hemmingway; D Fisher; T Berkery; D M Murray; M E Kiely
Journal:  Eur J Nutr       Date:  2020-07-17       Impact factor: 5.614

2.  Vitamin D Intake and Meeting Recommendations Among Infants Participating in WIC Nationally.

Authors:  Sina Gallo; Jaime Gahche; Panagiota Kitsantas; Priyal Makwana; Yu Wang; Xianyan Chen; Janani Rajbhandari-Thapa
Journal:  J Nutr Educ Behav       Date:  2022-03-11       Impact factor: 2.822

3.  Correction of neonatal vitamin D status using 1000 IU vitamin D/d increased lean body mass by 12 months of age compared with 400 IU/d: a randomized controlled trial.

Authors:  Maryam Razaghi; Nathalie Gharibeh; Catherine A Vanstone; Olusola F Sotunde; Ali Khamessan; Shu Q Wei; Dayre McNally; Frank Rauch; Glenville Jones; Sarah Kimmins; Hope A Weiler
Journal:  Am J Clin Nutr       Date:  2022-06-07       Impact factor: 8.472

4.  A closer look at rickets and vitamin D deficiency in Manitoba: The tip of the iceberg.

Authors:  Maria-Elena Lautatzis; Atul Sharma; Celia Rodd
Journal:  Paediatr Child Health       Date:  2018-08-13       Impact factor: 2.253

5.  Differential low uptake of free vitamin D supplements in preterm infants: the Quebec experience.

Authors:  Tarah Fatani; Atul K Sharma; Hope A Weiler; Odile Sheehy; Anick Bérard; Celia Rodd
Journal:  BMC Pediatr       Date:  2014-11-30       Impact factor: 2.125

Review 6.  Nutritional Rickets and Osteomalacia in the Twenty-first Century: Revised Concepts, Public Health, and Prevention Strategies.

Authors:  Suma Uday; Wolfgang Högler
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

7.  Vitamin D-Deficient Rickets in Japan.

Authors:  Mitsuko Itoh; Jun Tomio; Satoshi Toyokawa; Mayuko Tamura; Tsuyoshi Isojima; Sachiko Kitanaka; Yasuki Kobayashi
Journal:  Glob Pediatr Health       Date:  2017-06-01

8.  Trends in the Diagnosis of Vitamin D Deficiency.

Authors:  Emre Basatemur; Laura Horsfall; Louise Marston; Greta Rait; Alastair Sutcliffe
Journal:  Pediatrics       Date:  2017-02-03       Impact factor: 7.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.